 NEW YORK, Dec. 25, 2022 GLOBE NEWSWIRE Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. NASDAQ: SPPI, and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 22-cv-10677, is on behalf of a class ... The post SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Acton Law... 